Belite Bio CFO Hao-Yuan Chuang Sells 6,200 ADS Shares Under 10b5-1 Plan

Hao-Yuan Chuang, Chief Financial Officer and Director of Belite Bio, Inc. (BLTE), sold 6,200 American Depositary Shares (ADS) on April 9, 2026, through multiple transactions at prices ranging from $180.00 to $183.21 per share. The sales were executed pursuant to a Rule 10b5-1 trading plan adopted on December 22, 2025, which allows insiders to establish predetermined trading plans for selling shares. Following these transactions, Chuang's direct holdings decreased from 100,000 ADS to 93,800 ADS. The sales represent approximately 6.2% of his reported holdings. Each ADS represents one ordinary share of the company. The filing indicates these were planned transactions rather than discretionary sales, which may be viewed as less concerning by investors compared to unplanned insider selling.